Literature DB >> 30982828

Analysis of NKX2-5 in 439 Chinese Patients with Sporadic Atrial Septal Defect.

Hongshu Wang1,2, Yong Liu3, Yaxiong Li1, Wenju Wang1,2, Lin Li1,2, Mingyao Meng1, Yanhua Xie1, Yayong Zhang1, Zi Yunfeng1, Shen Han1,2, Jianying Zeng1,2, ZongLiu Hou1,2,2, Lihong Jiang4.   

Abstract

BACKGROUND The NKX2 gene family is made up of core transcription factors that are involved in the morphogenesis of the vertebrate heart. NKx2-5 plays a pivotal role in mouse cardiogenesis, and mutations in NKx2-5 result in an abnormal structure and function of the heart, including atrial septal defect and cardiac electrophysiological abnormalities. MATERIAL AND METHODS To investigate the genetic variation of NKX2-5 in Chinese patients with sporadic atrial septal defect, we sequenced the full length of the NKX2-5 gene in the participants of the study. Four hundred thirty-nine patients and 567 healthy unrelated individuals were recruited. Genomic DNA was extracted from the peripheral blood leukocytes of the participants. DNA samples from the participants were amplified by multiplex PCR and sequenced on an Illumina HiSeq platform. Variations were detected by comparison with a standard reference genome and annotation with a variant effect predictor. RESULTS Thirty variations were detected in Chinese patients with sporadic atrial septal defect, and 6 single nucleotide polymorphisms (SNPs) had a frequency greater than 1%. Among the 30 variations, the SNPs rs2277923 and rs3729753 were extremely prominent, with a high frequency and odds ratio in patients. CONCLUSIONS Single nucleotide variations are the prominent genetic variations of NKX2-5 in Chinese patients with sporadic atrial septal defect. The SNPs rs2277923 and rs3729753 are prominent single nucleotide variations (SNVs) in Chinese patients with sporadic atrial septal defect.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30982828      PMCID: PMC6481236          DOI: 10.12659/MSM.916052

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

The heart is an extremely important dynamic organ. The development of the heart is complex and involves many signaling pathways and transcription factors [1-3]. Many factors, such as environment factors, maternal factors, special medicine taken during pregnancy, genetic variations and so on [4-9], may disturb these regulated factors and lead to an aberrant structure and function of the heart, potentially resulting in congenital heart disease (CHD). CHD includes atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus, tetralogy of Fallot and so on. Among them, ASD is one of the most common subtypes of CHD [10]. Human NKX2-5, murine Nkx2-5, and Drosophila tinman all belong to the NK homeobox gene family, which includes a conserved homeodomain [11] and plays a crucial role in the development of the heart, regulating the proliferation, differentiation, and electrophysiological properties of cardiac cells. In mice, Nkx2-5 is expressed in progenitor cells of the heart in the first heart field (FHF), second heart field (SHF), and pharyngeal endoderm [12,13], and it is necessary and sufficient for the development of the SHF [13] and a determinate of differentiation into the myocardial lineage [12]. In the SHF of mice, NKx2-5 regulates the proliferation of heart progenitors and the morphology of the outflow tract [14]. In zebrafish, Nkx genes regulate electrophysiological patterning [15]. Mutations in murine NKx2-5 result in embryonic death and an abnormal structure and function of heart, including contraction defects, valvular dysmorphogenesis, atrial septal defect, ventricular noncompaction cardiomyopathy, and arrhythmias [16-22]. The aforementioned results demonstrate that NKx2-5 is a core regulatory transcription factor in cardiogenesis, and that disruption of NKx2-5 results in an abnormal structure and function of heart. However, the pathogenic mechanism of NKX2-5 in Chinese patients with sporadic atrial septal defect is unclear. To investigate the genetic variation of NKX2-5 in Chinese patients with sporadic atrial septal defect, we performed sequence analysis on full length NKX2-5.

Material and Methods

Study participants

For this study, 439 patients with sporadic atrial septal defect (157 males and 282 females) and 567 healthy unrelated individuals (274 males and 293 females) were recruited. Patients were recruited from the Department of Cardiovascular Surgery at Yan’an Affiliated Hospital of Kunming Medical University. Healthy unrelated individuals, confirmed by a medical examination and cardiac color Doppler ultrasound, were recruited from our previous epidemiological investigation. The ethnic groups of the participants included Han, Bai, Yi, Dai, and so on. There was no obvious ethnic group difference between the patients and the healthy controls. Diagnosis of ASD was confirmed by cardiac color Doppler ultrasound and findings during cardiac surgery, and other CHDs, such as ventricular septal defect, tetralogy of Fallot, Ebstein anomaly, patent ductus arteriosus, endocardial cushion defect, and Holt-Oram syndromes, were exclusion criteria for this study. This study was approved by the institutional research ethics committee of Yan’an Affiliated Hospital of Kunming Medical University. All participants or their parents provided informed consent. Genomic DNA was extracted from the peripheral blood leukocytes of the participants.

Primers

Primers (Table 1) were designed to amplify full-length NKX2-5. The specificity and efficiency of the primers was validated by polymerase chain reaction (PCR). The amplification system and experimental procedure of PCR are described in the supplementary data (Supplementary Tables 1, 2).
Table 1

Primers for multiplex PCR.

ID of ampliconsPrimer sequence
Forward primerReverse primer
Primer1.1-FTTCCAGCAAGGGTTAGGTTTTGCACCCACCCGTATTTATGTTT
Primer1.2-FACACGTGCGGGGTCAACGGAGAGTCCATGGGCACCCC
Primer1.3-FCCCTGGCTCGCGGAATGTGCGGAGACCTAGGAACTTTT
Primer1.4-FCAGGATCACTCATTGCACGCCCGAGCCTGGTAGGGAAGG
Primer1.5-FCATGTTGGGAGCCCCTTCTCCTGCCGCCGCCAACAA
Primer1.6-FGGAATCCCGGGGCTCTGGCCTGCCTACGGCGTGG
Primer1.7-FCGCGCCGCCGTAACCGCAGGACCAGACTCTGGAGC
Primer1.8-FCACTGGCACCGCGATCCTCGCAGGCGCAGGTCTAT
Primer1.9-FCGTGGACGTGAGTTTCAGCACGCGCTGCAGAAGGCGG
Primer1.10-FGTCCGCCTCTGTCTTCTCCATGTCGGTGGCTCCCAGTG
Primer1.11-FGTAAGAGCGGCTTGACCTACGCGTCTGTCTCCCTCACCAGG
Primer1.12-FTAGAAAGTCAGGCTGGCTCAATCTGTTCATTTAACTTCTCAAACCA
Primer1.13-FAAACCAGGTGATGCTCTGGGCCCGCAGCTTCTTGGACAC
Primer1.14-FCAAAATTAAGGAATCAAGAAACAGAATTTGTTGAGGAGCAGAGGCC
Primer1.15-FGGCTTCCTCGAATTGGTAGCCCCCGCTGCAGAAAGGG
Primer1.16-FTTCGCCCAGCGCTTCGGGGCGGAGAGGTTCCCTC
Primer1.17-FCACTCATCTCGTCCACTCCCTTGGGTTTCTGGTGCCTTTCTT
Primer1.18-FGGTCCGCAGTATCCCATTTTAATCTCCTTTGGATTTACGAATCTTT
Primer1.19-FGATTGTACGCAAAAGCTGTCTGGGCCTAACAAAGCCCCGG
Primer1.20-FGATTTCTCAACTTCCTACCAGACCGAGACACGCGCCCTTGG
Primer1.21-FTCTGAACCTCCGATTGGACGCCAGCCAAGGACCCTAGAGC
Primer1.22-FGACCCAGGAGGGGAGAAGGTCAAGCCAGAGGCCTACGCT
Primer1.23-FGAAAGGCAGACGCACACTTGTCAAAGACATCCTAAACCTGGAA
Primer1.24-FGCCAGGGTCGCCTCCAGCGGCACCATGCAGGG
Primer1.25-FGGCAGCGCCAGTCTCACAGGCCCCTGGCCCAATG
Primer1.26-FAGCAGGTAGCGCTGAGCACACCTTCCAAATGCGTCGTGG

Multiplex PCR and qPCR

Multiplex PCR was performed twice to amplify full-length NKX2-5. The amplification system and experimental procedure of multiplex PCR are described in the supplementary data (Supplementary Tables 3–6). The accuracy and efficiency of the multiplex PCR were validated by quantitative polymerase chain reaction (qPCR). The amplification system and experimental procedure of qPCR are described in the supplementary data (Supplementary Tables 7, 8).

Variation detection and statistical analysis

The products of multiplex PCR were mixed to form the sequencing library. An Illumina HiSeq platform was used to sequence the library. Human reference genome sequences (Edition: GRCh38.p7) and Burrows-Wheeler Alignment (BWA) (Edition: 0.1.22) were used to compare the sequences of the samples with the standard reference genome sequences. Detection of variation was processed by a genome analysis toolkit (GATK, Edition: v3.1). An online software variant effect predictor was used to annotate the variation. A square test was used to compare the 2 samples. SPSS 22.0 (IBM, USA) was used to analyze the data. A P-value <0.05 was used to indicate a statistically significant difference.

Results

Collation and statistics of raw data

The Q30 for all of the samples was greater than 90%. The total reads of NKX2-5 were 147 014 508 bp. After filtering, the reads of NKX2-5 were 145502856 bp. The total reads of NKX2-5 matched to the reference sequence were 79 266 998 bp. After filtering, the corrected reads were 66 473 696 bp. The average depth of the sequencing of each amplicon was approximately 5800-fold.

Thirty variations detected in 439 patients

Through comparison with the standard reference genome sequences, 30 variations (Supplementary Table 9) were detected in patients. The 30 variations included 18 single nucleotide polymorphisms (SNPs) and 12 novel variations (without rs number). The 18 SNPs were rs2277923, rs703752, rs3131915, rs3729753, rs376790353, rs549757001, rs562842387, rs531139209, rs892817393, rs1004442524, rs540202205, rs375010127, rs202071628, rs553775519, rs759221178, rs767243751, rs72554029, and rs551687864. The 12 novel variations, described as chromosomal locations, are 173233943, 173234153, 173233940, 173233733, 173232329, 173233307, 173234249, 173235293, 173234696, 173234963, 173235001, and 173233307. Six SNPs of the 30 variations had a high frequency greater than 1%. The 6 high-frequency SNPs in the 439 patients are listed in Table 2.
Table 2

Six high-frequency SNPs detected in 439 patients.

LOC1rs numberREFALTAACLOC2SNP (n=439)Frequency (%)
173235021rs2277923TCGlu > GluExtron35280.18
173232508rs703752CANone3/UTR7316.63
173233891rs3131915CGNoneIntron6815.49
173232938rs3729753CGLeu > LeuExtron214.78
173233982rs376790353CANoneIntron92.05
173233290rs549757001GANoneIntron81.82

LOC1 – position in the chromosome; REF – reference genomic locus information; ALT – locus variation information in the sample; AAC – amino acid change; LOC2 – position in the NKX2-5; SNPs – single nucleotide polymorphisms.

Two SNPs detected in 567 healthy controls

Two SNPs (Table 3) were detected in healthy controls. These SNPs were rs703752 and rs2277923 and had frequencies of 68.78% and 15.17%, respectively.
Table 3

Two SNPs detected in healthy controls.

LOC1rs numberREFALTAACLOC2SNP (n=567)Frequency (%)
173232508rs703752CAnone3/UTR39068.78
173235021rs2277923GAGlu>GluExtron8615.17

LOC1 – position in the chromosome; REF – reference genomic locus information; ALT – locus variation information in the sample; AAC – amino acid change; LOC2 – position in the NKX2-5; SNPs – single nucleotide polymorphisms.

rs2277923 and rs3729753 are prominent SNVs with a high frequency and odds ratio in patients

Among the 30 variations, rs2277923 and rs3729753 were prominent with a high frequency and odds ratio (Table 4) in patients.
Table 4

χ2, P-value and OR of SNPs in ASD versus control.

SNPASD (n=439)Control (n=567)χ2, P-valueOR, 95%CI
rs227792335286χ2=425.45, P<0.0015.286 (4.328–6.458)
rs3729753210χ2=27.70, P<0.00127.123 (3.663–200.858)
rs70375273390χ2=270.92, P<0.0010.242 (0.195–0.300)
rs20207162810χ2=1.293, P=0.2560.998 (0.993–1.002)

OR – odds ratio; ASD – atrial septal defect; SNP – single nucleotide polymorphisms.

Discussion

In this study, we sequenced full-length NKX2-5 and detected 30 variations of NKX2-5 in Chinese patients with sporadic atrial septal defect. Six of the 30 variations had a frequency greater than 1%. The SNPs rs2277923 and rs3729753 were prominent SNVs with a high frequency and odds ratio in Chinese patients with sporadic atrial septal defect. Human NKX2-5 consisted of 3218 bp located at 5q35.1 and encoded 3 isoforms through pre-RNA splicing. The 3 isoforms were isoform 1, isoform 2, and isoform 3. Isoform 1 has the homeodomain, which is strictly expressed in the heart, and is the most abundant isoform in heart tissue. Isoform 2 and isoform 3 lack the homeodomain and have a low abundance in heart tissue [23]. Isoform 1 consists of 324 amino acids, which contain an evolutionarily conserved homeodomain-containing domain (HD, amino acids 138–197) in the middle, a tinman domain (TN, amino acids 10–21) at the N-terminus, a nuclear localization signal (NLS) near the N-terminus of the homeodomain, a NK2-specific domain (NK2, amino acids 212–234) at the C-terminus [11,24-26], and a tyrosine-rich homophilic interaction domain (YRD) near the NK2 domain [27,28]. The HD domain is involved in DNA binding activity and transcriptional activation [29]. The NLS domain could influence the location of NKX2-5 by phosphorylation and dephosphorylation [30]. The NK2 domain functions as a regulator of transcriptional activation [31]. The YRD domain is essential for the function of NKX2-5 in cardiogenesis and embryonic development [27]. The function of the TN domain is still unclear. As a crucial transcriptional factor, NKX2-5 is a regulator of the development of the heart [1-3,32,33] that functions by binding its downstream targets through its functional domain, such as the HD domain, TN domain, NK domain, and YRD domain [28,31,34,35]. In this study, we detected 30 genetic variations of NKX2-5 in patients with sporadic atrial septal defect, and no frameshift mutations or insertion/deletion mutations were detected. These results demonstrate that single nucleotide variations (SNVs) are the prominent genetic variations of NKX2-5 in Chinese patients with sporadic atrial septal defect. Among them, 6 SNPs had a high frequency greater than 1%. These SNPs were distributed in the exons, introns, and 3′UTR of NKX2-5. Although these SNPs did not change the amino acid sequence and structure of the domains of NKX2-5, we still considered these variations, especially the SNPs rs2277923 and rs3729753, to have the potential and ability to cause sporadic atrial septal defect for the following reasons. First, compared with healthy people, patients with sporadic atrial septal defect had a high frequency of and odds ratio for rs2277923 and rs3729753. Second, although synonymous SNVs did not change the structure of the protein, a synonymous SNV can influence the structure of the pre-RNA and the binding to RNA binding protein [36,37]. Pre-RNA of NKX2-5 was spliced through an alternative splicing mechanism to generate 3 isoforms. The presence of an SNV may influence the recognition and binding of the RNA binding protein and spliceosomes. The presence of an SNV may also influence the stability and degradation of RNA in the cytoplasm [36,37]. Third, as a crucial transcription factor, the regulatory functions of NKX2-5 depended on its quality and abundance. SNV might influence the RNA level, resulting in changes in the abundance and distribution of the transcript of NKX2-5, which then disturbs the downstream targets of NKX2-5.

Conclusions

Single nucleotide variations are the prominent genetic variations of NKX2-5 in Chinese patients with sporadic atrial septal defect. The SNPs rs2277923 and rs3729753 are prominent SNVs in Chinese patients with sporadic atrial septal defect. A pathogenic mechanism of rs2277923 and rs3729753 may exist at the RNA level. Further studies are needed to validate this possibility. Amplification system of PCR. Experimental procedure of PCR. Amplification system of the first turn multiplex PCR. Experimental procedure of the first turn multiplex PCR. Amplification system of the second turn multiplex PCR. Experimental procedure of the second turn multiplex PCR. Amplification system of qPCR. Experimental procedure of qPCR. 30 variations detected in 439 patients. LOC – position in the chromosome; REF – reference genomic locus information; ALT – locus variation information in the sample.
Supplementary Table 1.

Amplification system of PCR.

Reagent componentVolumeConcentration
Buffer (10×)1 uL
Primer (1 uM)2 uL
dNTP (2.5 mM)0.8 uL
DNA polymerase (5 U/uL)0.1 uL
Template DNA2 uL
Mg2+ (100 mM)1 uL
ddH2O3.2 uL
Paraffin oil10 uL
Supplementary Table 2.

Experimental procedure of PCR.

StepTemperatureTimeCycle
195°C15 min1 cycle
294°C30 s
360°C90 s35 cycles
472°C30 s
572°C10 min1 cycle
Supplementary Table 3.

Amplification system of the first turn multiplex PCR.

Reagent componentVolumeConcentration
Buffer (10×)1 uL
Primer (50 nM)2 uL
dNTP (2.5 mM)0.8 uL
DNA polymerase (5 U/uL)0.1 uL
Template DNA2 uL
Mg2+ (100 mM)1 uL
ddH2O3.2 uL
Paraffin oil10 uL
Supplementary Table 4.

Experimental procedure of the first turn multiplex PCR.

StepTemperatureTimeCycle
195°C15 min1 cycle
294°C30 s
360°C10 min4 cycles
472°C30 s
594°C30 s
660°C1 min20 cycle
772°C30 s
Supplementary Table 5.

Amplification system of the second turn multiplex PCR.

Reagent componentVolumeConcentration
Buffer (10×)2 uL
Barcode (2 uM)3.6 uL
dNTP (2.5 mM)0.8 uL
DNA polymerase (5 U/uL)0.1 uL
Template DNA10 uL
Mg2+ (100 mM)1 uL
ddH2O3.6 uL
Paraffin oil20 uL
Supplementary Table 6.

Experimental procedure of the second turn multiplex PCR.

StepTemperatureTimeCycle
195°C15 min1 cycle
294°C30 s
360°C4 min5 cycles
472°C30 s
594°C30 s
665°C1 min10 cycle
772°C30 s
Supplementary Table 7.

Amplification system of qPCR.

Reagent componentVolumeConcentration
Mix6 uL
Primer (1 uM)2 uL
Template DNA1.8 uL
ROX0.24 uL
ddH2O2 uL
Supplementary Table 8.

Experimental procedure of qPCR.

StepTemperatureTimeCycle
195°C2 min1 cycle
294°C30 s
360°C30 s35 cycles
472°C30 s
Supplementary Table 9.

30 variations detected in 439 patients.

LOCrs numberREFALTSNP (n=439)Frequency (%)
173235021rs2277923TC35280.18
173232508rs703752CA7316.63
173233891rs3131915CG6815.49
173232938rs3729753CG214.78
173233982rs376790353CA92.05
173233290rs549757001GA81.82
173233943NoneCA40.91
173232370rs562842387CT30.68
173234153NoneAG20.46
173234425rs531139209CG20.46
173233698rs892817393AG20.46
173233940NoneGT20.46
173234640rs1004442524CT20.46
173232273rs540202205CG20.46
173233733NoneGA10.23
173232340rs375010127TC10.23
173232839rs202071628CG10.23
173232329NoneGT10.23
173232316rs553775519GT10.23
173233307NoneAT10.23
173234249NoneCT10.23
173235293NoneGC10.23
173234696NoneTC10.23
173234775rs759221178GA10.23
173234784rs767243751GT10.23
173234847rs72554029CG10.23
173234963NoneGA10.23
173235001NoneGA10.23
173233307NoneAT10.23
173233409rs551687864GA10.23

LOC – position in the chromosome; REF – reference genomic locus information; ALT – locus variation information in the sample.

  3 in total

1.  Association between single-nucleotide polymorphisms of NKX2.5 and congenital heart disease in Chinese population: A meta-analysis.

Authors:  Huan Chen; Tianjiao Li; Yuqing Wu; Xi Wang; Mingyuan Wang; Xin Wang; Xiaoling Fang
Journal:  Open Life Sci       Date:  2022-05-12       Impact factor: 1.311

2.  Mutations in the tail domain of MYH3 contributes to atrial septal defect.

Authors:  Sathiya Maran; Robson Ee; Siti Aisyah Faten; Choi Sy Bing; Kooi Yeong Khaw; Swee-Hua Erin Lim; Kok-Song Lai; Wan Pauzi Wan Ibrahim; Mohd Rizal Mohd Zain; Kok Gan Chan; Siew Hua Gan; Huay Lin Tan
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

3.  NKX2-5 variants screening in patients with atrial septal defect in Indonesia.

Authors:  Royhan Rozqie; Muhammad Gahan Satwiko; Dyah Wulan Anggrahini; Ahmad Hamim Sadewa; Anggoro Budi Hartopo; Hasanah Mumpuni; Lucia Kris Dinarti
Journal:  BMC Med Genomics       Date:  2022-04-22       Impact factor: 3.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.